Amwell (American Well) (AMWL) is a publicly traded Virtual Care Delivery company founded in 2006 and based in Boston, United States.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Sep 17, 2020 | IPO | $742M | — | — |
| May 20, 2020 | Series C | $194M | — | Allianz X, Takeda |
| Jul 2, 2018 |
| Growth |
| $291M |
| — |
| Philips, Allianz |
| Aug 7, 2015 | Undisclosed | $5M | — | InVenture Partners |
| Dec 16, 2014 | Series C | $81M | — | Anthem Health, Jefferson Health System |
Amwell reported Q3 2026 total revenue of $49.0 million, down from $56.3 million in the third quarter of 2025 (a decline of about 13%, computed from the two stated figures). Subscription revenue was $23.9 million and AMG visit revenue was $23.7 million; the company said revenue exceeded its prior Q3 guidance range. Gross margin was 53%. Net loss was $11.0 million, compared with $9.6 million in Q2 2026 as stated in the release. Adjusted EBITDA was a loss of $3.6 million, versus a loss of $1.2 million in Q2 2026. Total platform visits were 0.8 million. The company raised its 2026 revenue outlook to $204–206 million (from $200–205 million) and its adjusted EBITDA outlook to a loss of $7–8 million (from a loss of $7–9 million), and reaffirmed AMG visits of 1.32–1.37 million. Q4 2026 guidance is revenue of $48–50 million and adjusted EBITDA of $0–1 million. The company reiterated its objective of positive operating cash flow in Q4 2026. The release notes that the outlook depends on, among other things, the Defense Health Agency continuing its relationship with comparable terms.
FY2026 revenue $204–206M and adjusted EBITDA ($8)–($7)M; Q4 2026 revenue $48–50M and adjusted EBITDA $0–1M; positive operating cash flow targeted in Q4 2026
Amwell Converge is the company's flagship enterprise telehealth platform that enables health systems, health plans, and employers to deliver virtual care across the care continuum — from acute and urgent care to chronic condition management and behavioral health. It features built-in EHR integration, an open architecture supporting third-party clinical applications, and a single meeting place for providers and patients. Converge shifts care from episodic telehealth transactions to longitudinal hybrid care strategies, allowing organizations to unify in-person, virtual, and automated care delivery at scale.
Amwell Now is a direct-to-consumer on-demand telehealth offering powered by the Converge platform. It provides patients with 24/7 access to board-certified clinicians for urgent care needs, including cold and flu symptoms, infections, allergies, and dermatology issues. Amwell Now enables health plans and employers to offer their members and employees convenient, immediate care from any device, with no appointment needed, helping reduce unnecessary emergency room visits and lower overall healthcare costs.
Amwell Behavioral Health is a comprehensive digital behavioral health solution that connects patients with licensed therapists, psychiatrists, and behavioral health coaches through secure video visits. It covers a wide range of mental health services including individual therapy, psychiatric medication management, and substance use disorder support. The program integrates with the Converge platform to provide a unified care experience, enabling health plans and employers to offer scalable, accessible mental healthcare that reduces stigma and improves outcomes.
Amwell Chronic Care Management is a virtual care program designed to help patients manage ongoing conditions such as diabetes, hypertension, heart disease, and asthma. It combines remote patient monitoring, regular video check-ins with clinicians, and personalized care plans to keep patients engaged between visits. The program leverages the Converge platform's data integration capabilities to give providers real-time insights into patient health trends, enabling early interventions that prevent complications and hospital readmissions.